I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 25% ± 9% | |
| ciliated cell | 6 studies | 29% ± 9% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 17% ± 2% | |
| epithelial cell | 4 studies | 40% ± 10% | |
| natural killer cell | 4 studies | 17% ± 1% | |
| fibroblast | 3 studies | 24% ± 5% | |
| erythroblast | 3 studies | 31% ± 16% | |
| endothelial cell of lymphatic vessel | 3 studies | 24% ± 7% | |
| GABAergic neuron | 3 studies | 22% ± 3% | |
| glutamatergic neuron | 3 studies | 29% ± 7% | |
| basal cell | 3 studies | 35% ± 10% |
